Penn Pharma has completed the first phase of its $19.7 million expansion program with a $.5 million investment extending its facilities by 2,400m2 and changing the transport and delivery infrastructure at its Tredegar headquarters. Darren Hassey, chief operating officer at Penn Pharma, said, “The recent developments to the site only add to our established offerings. By altering the externals of the site and moving the delivery and collection points we have in turn altered the internal factory...